S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
North Carolina medical marijuana sales begin at Cherokee store
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It’s not that clear-cut
Ukrainian and Western leaders laud US aid package while the Kremlin warns of 'further ruin'
'Civil War’ continues box-office campaign at No. 1
Conservative Brazilians laud Elon Musk at rally in support of ex-president Bolsonaro
Tens of thousands of Colombians protest against the leftist president's reform agenda
Stock market today: Asian shares shrug off Wall St blues as China leaves lending rate unchanged

Ironwood Pharmaceuticals (IRWD) News Today

$7.92
+0.32 (+4.21%)
(As of 04/19/2024 08:50 PM ET)
SourceHeadline
nasdaq.com logoGuru Fundamental Report for IRWD
nasdaq.com - April 20 at 10:27 AM
MarketBeat logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Sees Large Increase in Short Interest
americanbankingnews.com - April 16 at 5:00 AM
marketbeat.com logoIronwood Pharmaceuticals (NASDAQ:IRWD) Reaches New 52-Week Low at $7.78
marketbeat.com - April 15 at 2:48 PM
marketbeat.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Short Interest Update
marketbeat.com - April 14 at 7:21 PM
marketbeat.com logoIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 2.9%
marketbeat.com - April 8 at 2:28 PM
marketbeat.com logoIronwood Pharmaceuticals (NASDAQ:IRWD) Sets New 52-Week Low at $8.07
marketbeat.com - April 3 at 5:31 PM
markets.businessinsider.com logoPiper Sandler Reaffirms Their Buy Rating on Ironwood Pharma (IRWD)
markets.businessinsider.com - April 1 at 2:01 PM
marketbeat.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Average Rating of "Buy" from Analysts
marketbeat.com - April 1 at 4:14 AM
marketbeat.com logoIronwood Pharmaceuticals (NASDAQ:IRWD) Upgraded to "Buy" by StockNews.com
marketbeat.com - March 29 at 11:15 PM
markets.businessinsider.com logoAnalysts Are Bullish on Top Healthcare Stocks: Mediwound (MDWD), Ironwood Pharma (IRWD)
markets.businessinsider.com - March 28 at 11:02 PM
businesswire.com logoIronwood Pharmaceuticals Announces Positive Results from its Phase II Exploratory STARGAZE Trial of Apraglutide in Patients with Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease (SR GI aGVHD)
businesswire.com - March 28 at 7:30 AM
marketbeat.com logoEquities Analysts Set Expectations for Ironwood Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:IRWD)
marketbeat.com - March 22 at 8:19 AM
marketbeat.com logoResearch Analysts Offer Predictions for Ironwood Pharmaceuticals, Inc.'s Q4 2024 Earnings (NASDAQ:IRWD)
marketbeat.com - March 21 at 8:06 AM
nasdaq.com logoValidea Detailed Fundamental Analysis - IRWD
nasdaq.com - March 20 at 4:29 PM
marketbeat.com logoWalleye Capital LLC Purchases Shares of 166,968 Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
marketbeat.com - March 19 at 4:21 AM
msn.com logoIronwood Pharmaceuticals (NASDAQ:IRWD): Analysts Stay Bullish Despite Recent Stock Plunge
msn.com - March 16 at 3:50 PM
insidertrades.com logoInsider Buying: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) CFO Acquires 10,684 Shares of Stock
insidertrades.com - March 16 at 10:15 AM
finance.yahoo.com logoIt’s Time! 3 Failing Biotech Stocks to Sell Right Now
finance.yahoo.com - March 13 at 2:01 AM
marketbeat.com logo2,378,295 Shares in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Purchased by Jacobs Levy Equity Management Inc.
marketbeat.com - March 12 at 8:38 AM
insidertrades.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Director Purchases $60,204.00 in Stock
insidertrades.com - March 11 at 7:38 AM
marketbeat.com logoQ1 2025 EPS Estimates for Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Cut by Zacks Research
marketbeat.com - March 11 at 2:50 AM
marketbeat.com logoAdage Capital Partners GP L.L.C. Boosts Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
marketbeat.com - March 7 at 7:44 AM
marketbeat.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Recommendation of "Buy" by Analysts
marketbeat.com - March 7 at 5:47 AM
marketbeat.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) to Post Q1 2024 Earnings of $0.18 Per Share, Zacks Research Forecasts
marketbeat.com - March 6 at 7:32 AM
investorplace.com logoIt's Time! 3 Failing Biotech Stocks to Sell Right Now
investorplace.com - March 5 at 1:05 PM
marketbeat.com logoGlenmede Trust Co. NA Raises Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
marketbeat.com - March 4 at 9:28 AM
finance.yahoo.com logoIRWD Mar 2024 5.000 put
finance.yahoo.com - March 3 at 6:15 PM
marketbeat.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by 13D Management LLC
marketbeat.com - March 3 at 12:28 PM
msn.com logoIronwood plunges nearly 40% after SBS trial misses secondary goals
msn.com - March 1 at 4:09 PM
reuters.com logoIronwood's bowel disease drug meets main goal of late-stage study
reuters.com - March 1 at 4:09 PM
marketbeat.com logoWells Fargo & Company Trims Ironwood Pharmaceuticals (NASDAQ:IRWD) Target Price to $14.00
marketbeat.com - March 1 at 1:41 PM
marketbeat.com logoIronwood Pharmaceuticals (NASDAQ:IRWD) Trading Down 5.7%
marketbeat.com - March 1 at 12:15 PM
markets.businessinsider.com logoIronwood Pharmaceuticals: Strong Buy Rating on LINZESS Performance and Apraglutide Market Potential
markets.businessinsider.com - February 29 at 11:53 PM
finance.yahoo.com logoIronwood Pharmaceuticals Ran Up 32% Over Two Months — And Just Lost It All
finance.yahoo.com - February 29 at 1:52 PM
reuters.com logoIronwood says bowel disease treatment meets main goal in late-stage trial
reuters.com - February 29 at 8:52 AM
markets.businessinsider.com logoIronwood Pharma: Apraglutide Trial Meets Primary Goal, But Some Secondary Goals Not Met; Stock Dips
markets.businessinsider.com - February 29 at 8:52 AM
msn.com logoWhy Is Ironwood Pharmaceuticals (IRWD) Stock Down 27% Today?
msn.com - February 29 at 8:52 AM
finance.yahoo.com logoIronwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
finance.yahoo.com - February 29 at 8:52 AM
marketbeat.com logoCharles Schwab Investment Management Inc. Has $11.85 Million Position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
marketbeat.com - February 28 at 4:25 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Blueprint Medicines (BPMC), AMN Healthcare Services (AMN) and Ironwood Pharma (IRWD)
markets.businessinsider.com - February 26 at 8:07 AM
marketbeat.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Purchased by UBS Group AG
marketbeat.com - February 24 at 4:34 AM
businesswire.com logoIronwood Pharmaceuticals to Present Four Abstracts at the ASPEN 2024 Nutrition Science & Practice Conference
businesswire.com - February 23 at 7:30 AM
marketbeat.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Commonwealth of Pennsylvania Public School Empls Retrmt SYS
marketbeat.com - February 22 at 5:16 AM
marketbeat.com logoQRG Capital Management Inc. Makes New Investment in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
marketbeat.com - February 20 at 7:04 AM
marketbeat.com logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Quantedge Capital Pte Ltd
marketbeat.com - February 19 at 10:27 AM
marketbeat.com logoCapital One Financial Weighs in on Ironwood Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:IRWD)
marketbeat.com - February 19 at 3:27 AM
marketbeat.com logoRafferty Asset Management LLC Has $8.42 Million Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)
marketbeat.com - February 18 at 7:28 AM
finance.yahoo.com logoIronwood Pharmaceuticals Full Year 2023 Earnings: EPS Misses Expectations
finance.yahoo.com - February 17 at 10:39 AM
finance.yahoo.com logoIronwood (IRWD) Q4 Earnings Miss, Revenues Beat Marginally
finance.yahoo.com - February 16 at 1:18 PM
marketbeat.com logoIronwood Pharmaceuticals (NASDAQ:IRWD) Price Target Increased to $21.00 by Analysts at Piper Sandler
marketbeat.com - February 16 at 11:16 AM
Get Ironwood Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter.

Healthcare Takes A Big Step Forward With The Help Of AI (Ad)

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

IRWD Media Mentions By Week

IRWD Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

IRWD
News Sentiment

0.33

0.49

Average
Medical
News Sentiment

IRWD News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

IRWD Articles
This Week

3

3

IRWD Articles
Average Week

Get Ironwood Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRWD and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:IRWD) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners